Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: William Rastetter, Ajay Bansal

Premium

Regulus has appointed William Rastetter to its board of directors. Rastetter is currently chairman of the board of Illumina, Fate Therapeutics, Neurocrine Biosciences, and Receptos. He holds a PhD and MA in chemistry from Harvard University.


Onconova has appointed Ajay Bansal chief financial officer. Bansal most recently served as chief financial officer for Complete Genomics. He has also served as chief financial officer and executive vice president of corporate and business development for Lexicon Therapeutics and Tercica. He has also worked in strategy and marketing for Novartis Pharmaceuticals and held positions at consulting firms such as McKinsey & Company. He holds master's degrees in management and operations research from Northwestern University.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.